Rare diseases
Investigational molecules
Locations
Study of Chemotherapy with Osimertinib in Non-Small Cell Lung Cancer Patients Who Have Progressed After Initial Osimertinib Treatment
GermanyA study comparing TAP block versus QL block with ropivacaine for pain management after laparoscopic colon resection in patients with colon cancer or diverticulosis
FinlandStudy on the Effectiveness and Safety of Vosoritide for Children with Hypochondroplasia
FranceStudy Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma
BelgiumStudy of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer
AustriaStudy on Long-Term Safety and Effects of Pegcetacoplan for Patients with Geographic Atrophy from Age-Related Macular Degeneration
CzechiaStudy on Continued Treatment with Sabatolimab for Adults with High-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Unfit for Chemotherapy
CzechiaStudy of Intrathecal Cebsulfase Alfa for Children with Late Infantile Metachromatic Leukodystrophy
BelgiumStudy on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer
LithuaniaStudy on the Effects of AS01B, Ipilimumab, and Nivolumab in Patients with Advanced Melanoma
BelgiumStudy on the Safety and Effects of Zanidatamab, Palbociclib, and Fulvestrant for Patients with Advanced or Metastatic HER2-Positive, HR-Positive Breast Cancer
SpainStudy on Infliximab and Tocilizumab for Patients with Refractory or Relapsing Takayasu Arteritis
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
